Article
Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol
7 May 1999
Abstract excerpt
A major impediment to the successful use of Taxol in the treatment of cancer is the development of drug resistance. The major cellular target of Taxol is the microtubule that is comprised of alpha- and beta-tubulin heterodimers. Binding sites for Taxol have been delineated on the beta-tubulin subunit that has six isotypes. We have recently described increased expression of the brain-specific human class III...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
